Rye, NY, United States of America

Frédérique Menzaghi

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Synthetic Peptide Amides. Top assignees: Cara Therapeutics, Inc., Arena Pharmaceuticals, Inc., Cera Therapeutics, Inc.. Active years: 2000-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frédérique Menzaghi. Retrieved from https://idiyas.com/inventor/frederique-menzaghi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 100.0

 


Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 494(Granted Patents)


Location History:

  • San Diego, CA (US) (2000 - 2002)
  • Rye, NY (US) (2008 - 2021)

Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Synthetic Peptide Amides
Kappa Opioid
Pain Management
G Protein-Coupled Receptor
Dimers
Small Molecule Modulators
Prolactin Elevation
Constitutively Activated
19 patents (USPTO):Explore Patents

Title: Frédérique Menzaghi: Innovator in Synthetic Peptide Amides

Introduction: Frédérique Menzaghi is an accomplished inventor based in Rye, NY, with an impressive portfolio of 14 patents to his name. His work primarily focuses on synthetic peptide amides, contributing significantly to the field of opioid receptor research.

Latest Patents: Among his latest innovations, Menzaghi has developed synthetic peptide amides and dimers that target the kappa opioid receptor. These inventions are particularly noteworthy as they present agonists that demonstrate low PCYP inhibition and minimal brain penetration. The compounds designed by Menzaghi are promising for the prophylaxis and treatment of pain and inflammation associated with a variety of diseases and conditions. Their structural formula details the particular configurations of these synthetic peptide amides, which further exemplify the ingenuity behind his research.

Career Highlights: Menzaghi's career has been marked by a dedication to advancing pharmaceutical solutions, particularly in pain management. He works at Cara Therapeutics, Inc., a company known for its innovative approaches to addressing pain and inflammatory diseases.

Collaborations: Throughout his career, Menzaghi has collaborated with experts in the field, including Claudio Daniel Schteingart and Guangcheng Jiang. These partnerships have been instrumental in driving forward the development of his synthetic peptide inventions and enhancing their clinical application.

Conclusion: Frédérique Menzaghi represents the innovative spirit within the pharmaceutical industry. His contributions through numerous patents illustrate a commitment to finding effective treatments for pain management, demonstrating the importance of synthetic peptide research in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…